166 related articles for article (PubMed ID: 32923127)
1. The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.
Weis-Banke SE; Hübbe ML; Holmström MO; Jørgensen MA; Bendtsen SK; Martinenaite E; Carretta M; Svane IM; Ødum N; Pedersen AW; Met Ö; Madsen DH; Andersen MH
Oncoimmunology; 2020 Jun; 9(1):1771142. PubMed ID: 32923127
[TBL] [Abstract][Full Text] [Related]
2. Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.
Weis-Banke SE; Lisle TL; Perez-Penco M; Schina A; Hübbe ML; Siersbæk M; Holmström MO; Jørgensen MA; Marie Svane I; Met Ö; Ødum N; Madsen DH; Donia M; Grøntved L; Andersen MH
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36316062
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment.
Steggerda SM; Bennett MK; Chen J; Emberley E; Huang T; Janes JR; Li W; MacKinnon AL; Makkouk A; Marguier G; Murray PJ; Neou S; Pan A; Parlati F; Rodriguez MLM; Van de Velde LA; Wang T; Works M; Zhang J; Zhang W; Gross MI
J Immunother Cancer; 2017 Dec; 5(1):101. PubMed ID: 29254508
[TBL] [Abstract][Full Text] [Related]
4. Frequent adaptive immune responses against arginase-1.
Martinenaite E; Mortensen REJ; Hansen M; Orebo Holmström M; Munir Ahmad S; Grønne Dahlager Jørgensen N; Met Ö; Donia M; Svane IM; Andersen MH
Oncoimmunology; 2018; 7(3):e1404215. PubMed ID: 29399404
[TBL] [Abstract][Full Text] [Related]
5. Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression.
Rotondo R; Mastracci L; Piazza T; Barisione G; Fabbi M; Cassanello M; Costa R; Morandi B; Astigiano S; Cesario A; Sormani MP; Ferlazzo G; Grossi F; Ratto GB; Ferrini S; Frumento G
Int J Cancer; 2008 Sep; 123(5):1108-16. PubMed ID: 18528866
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action.
Austin M; Burschowsky D; Chan DTY; Jenkinson L; Haynes S; Diamandakis A; Seewooruthun C; Addyman A; Fiedler S; Ryman S; Whitehouse J; Slater LH; Hadjinicolaou AV; Gileadi U; Gowans E; Shibata Y; Barnard M; Kaserer T; Sharma P; Luheshi NM; Wilkinson RW; Vaughan TJ; Holt SV; Cerundolo V; Carr MD; Groves MAT
MAbs; 2020; 12(1):1801230. PubMed ID: 32880207
[TBL] [Abstract][Full Text] [Related]
7. The arginase inhibitor Nω-hydroxy-nor-arginine (nor-NOHA) induces apoptosis in leukemic cells specifically under hypoxic conditions but CRISPR/Cas9 excludes arginase 2 (ARG2) as the functional target.
Ng KP; Manjeri A; Lee LM; Chan ZE; Tan CY; Tan QD; Majeed A; Lee KL; Chuah C; Suda T; Ong ST
PLoS One; 2018; 13(10):e0205254. PubMed ID: 30307989
[TBL] [Abstract][Full Text] [Related]
8. Arginase II expressed in cancer-associated fibroblasts indicates tissue hypoxia and predicts poor outcome in patients with pancreatic cancer.
Ino Y; Yamazaki-Itoh R; Oguro S; Shimada K; Kosuge T; Zavada J; Kanai Y; Hiraoka N
PLoS One; 2013; 8(2):e55146. PubMed ID: 23424623
[TBL] [Abstract][Full Text] [Related]
9. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.
Pass HA; Schwarz SL; Wunderlich JR; Rosenberg SA
Cancer J Sci Am; 1998; 4(5):316-23. PubMed ID: 9815296
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial arginase-2 is a cell‑autonomous regulator of CD8+ T cell function and antitumor efficacy.
Martí i Líndez AA; Dunand-Sauthier I; Conti M; Gobet F; Núñez N; Hannich JT; Riezman H; Geiger R; Piersigilli A; Hahn K; Lemeille S; Becher B; De Smedt T; Hugues S; Reith W
JCI Insight; 2019 Nov; 4(24):. PubMed ID: 31751318
[TBL] [Abstract][Full Text] [Related]
11. Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitope.
Martinenaite E; Ahmad SM; Bendtsen SK; Jørgensen MA; Weis-Banke SE; Svane IM; Andersen MH
Cancer Immunol Immunother; 2019 Nov; 68(11):1901-1907. PubMed ID: 31690955
[TBL] [Abstract][Full Text] [Related]
12. Arginase 1-Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti-PD-1 Checkpoint Blockade.
Aaboe Jørgensen M; Ugel S; Linder Hübbe M; Carretta M; Perez-Penco M; Weis-Banke SE; Martinenaite E; Kopp K; Chapellier M; Adamo A; De Sanctis F; Frusteri C; Iezzi M; Zocca MB; Hargbøll Madsen D; Wakatsuki Pedersen A; Bronte V; Andersen MH
Cancer Immunol Res; 2021 Nov; 9(11):1316-1326. PubMed ID: 34518197
[TBL] [Abstract][Full Text] [Related]
13. The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer.
Giatromanolaki A; Harris AL; Koukourakis MI
Cancer Metab; 2021 Aug; 9(1):28. PubMed ID: 34344457
[TBL] [Abstract][Full Text] [Related]
14. Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors - A phase I trial.
Lorentzen CL; Martinenaite E; Kjeldsen JW; Holmstroem RB; Mørk SK; Pedersen AW; Ehrnrooth E; Andersen MH; Svane IM
Front Immunol; 2022; 13():1023023. PubMed ID: 36330525
[TBL] [Abstract][Full Text] [Related]
15. The T-win® technology: immune-modulating vaccines.
Andersen MH
Semin Immunopathol; 2019 Jan; 41(1):87-95. PubMed ID: 29968045
[TBL] [Abstract][Full Text] [Related]
16. Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
Glöckner HJ; Martinenaite E; Landkildehus Lisle T; Grauslund J; Ahmad S; Met Ö; Thor Straten P; Hald Andersen M
Oncoimmunology; 2024; 13(1):2318053. PubMed ID: 38404966
[TBL] [Abstract][Full Text] [Related]
17. Repression of arginase-2 expression in dendritic cells by microRNA-155 is critical for promoting T cell proliferation.
Dunand-Sauthier I; Irla M; Carnesecchi S; Seguín-Estévez Q; Vejnar CE; Zdobnov EM; Santiago-Raber ML; Reith W
J Immunol; 2014 Aug; 193(4):1690-700. PubMed ID: 25009204
[TBL] [Abstract][Full Text] [Related]
18. ARG2 impairs endothelial autophagy through regulation of MTOR and PRKAA/AMPK signaling in advanced atherosclerosis.
Xiong Y; Yepuri G; Forbiteh M; Yu Y; Montani JP; Yang Z; Ming XF
Autophagy; 2014; 10(12):2223-38. PubMed ID: 25484082
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma.
Bron L; Jandus C; Andrejevic-Blant S; Speiser DE; Monnier P; Romero P; Rivals JP
Int J Cancer; 2013 Feb; 132(3):E85-93. PubMed ID: 22815199
[TBL] [Abstract][Full Text] [Related]
20. OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer.
Grzybowski MM; Stańczak PS; Pomper P; Błaszczyk R; Borek B; Gzik A; Nowicka J; Jędrzejczak K; Brzezińska J; Rejczak T; Güner-Chalimoniuk NC; Kikulska A; Mlącki M; Pęczkowicz-Szyszka J; Olczak J; Gołębiowski A; Dzwonek K; Dobrzański P; Zasłona Z
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
